Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifylline

Abken, 1992, Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro, J. Immunol, 149, 2785, 10.4049/jimmunol.149.8.2785 Alegre, 1991, Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome, Transplantation, 52, 674, 10.1097/00007890-199110000-00018 Benbernou, 1995, Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells, J. Cardiovasc. Pharmacol, 28, S75, 10.1097/00005344-199500252-00016 Bienvenu, 1992, Study of pentoxifylline induced modulation of TNFα and interleukin-6 secretion in healthy and septic patients by the use of an ex-vivo model on whole blood, Nouv. Rev. Fr. Hematol, 34, S65 Bienvenu, 1995, Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline, J. Cardiovasc. Pharmacol, 28, S80, 10.1097/00005344-199500252-00017 Burchett, 1988, Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes, J. Immunol, 140, 3473, 10.4049/jimmunol.140.10.3473 Cassatella, 1993, Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes, 178, 2207 De Forge, 1991, Kinetics of TNF, IL-6 and IL-8 gene expression in LPS-stimulated human whole blood, Biochem. Biophys. Res. Comm, 174, 18, 10.1016/0006-291X(91)90478-P De Groote, 1992, Direct stimulation of cytokines (IL-1β, TNFα, IL-6, IL-2, IFNγ and GM-CSF) in whole blood I. Comparison with isolated PBMC stimulation, Cytokine, 4, 239, 10.1016/1043-4666(92)90062-V De Wall Malefyt, 1991, Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, J. Exp. Med, 174, 1209, 10.1084/jem.174.5.1209 Del Prete, 1993, Human IL-10 is produced by both type 1 helper (Th 1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production, J. Immunol, 150, 353, 10.4049/jimmunol.150.2.353 Desch, 1989, Production of human tumor necrosis factor from whole blood ex-vivo, Lymphokine Res, 8, 141 Endres, 1991, Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cells, Immunology, 72, 56 Funk, 1995, Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A, Int. J. Immunopharmac, 17, 1007, 10.1016/0192-0561(95)00096-8 Haskill, 1988, Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes, J. Immunol, 140, 1690, 10.4049/jimmunol.140.5.1690 Hempel, 1995, Interleukin-10 directly inhibits the interleukin-6 production in T-cells, Scand. J. Immunol, 41, 462, 10.1111/j.1365-3083.1995.tb03593.x Hurme, 1990, Modulation of interleukin-1β production by cyclic AMP in human monocytes, FEBS Lett, 263, 35, 10.1016/0014-5793(90)80699-J Kambayashi, 1995, Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 by endotoxin-stimulated macrophages, J. Immunol, 155, 4909, 10.4049/jimmunol.155.10.4909 Krzanowski, 1988, Mechanism of action of methylxanthines in asthma, J. Allergy Clin. Immunol, 82, 145, 10.1016/0091-6749(88)90992-X Llorent, 1993, Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus, Eur. Cytokine Netw, 4, 421 Lu, 1993, Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression, J. Cell Biol, 120, 1281, 10.1083/jcb.120.5.1281 Matthes, 1993, Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor α, interleukin (IL)6, IL-10, and transforming growth factor β1 mRNAs, J. Exp. Med, 178, 521, 10.1084/jem.178.2.521 Neuner, 1994, Pentoxifylline in vivo down-regulates the release of IL-lβ, IL-6, IL-8 and tumor necrosis factor-α by human peripheral blood mononuclear cells, Immunology, 83, 262 Peng, 1995, Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide, Leukemia Res, 19, 159, 10.1016/0145-2126(94)00129-X Platzer, 1995, Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs, Int. Immunol, 7, 517, 10.1093/intimm/7.4.517 Porter, 1982, Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients, Am. Heart. J, 104, 66, 10.1016/0002-8703(82)90642-1 Rieneck, 1993, In vitro immunomodulatory effects of pentoxifylline, Immunol. Lett, 37, 131, 10.1016/0165-2478(93)90022-T Rott, 1993, Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats, Eur. J. Immunol, 23, 1745, 10.1002/eji.1830230802 Schandené, 1992, Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) by monocytes and T cells, Immunology, 76, 30 Schwab, 1991, Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266, Blood, 77, 587, 10.1182/blood.V77.3.587.587 Standiford, 1990, Interleukin-8 gene expression by a pulmonary epithelial cell line, 86, 1439 Strieter, 1988, Cellular and molecular regulation of TNF-alpha production by pentoxifylline, Biochem. Biophys. Res. Commun, 155, 1230, 10.1016/S0006-291X(88)81271-3 Strieter, 1990, Disparate gene expression of chematactic cytokines by human mononuclear phagocytes, Biochem. Biophys. Res. Commun, 166, 886, 10.1016/0006-291X(90)90893-R Thanhauser, 1993, Pentoxifylline: a potent inhibitor of IL-2 and IFN-γ biosynthesis and BCG-induced cytotoxicity, Immunology, 80, 151 Verghese, 1995, Differential regulation of human monocyte-derived TNFα and IL-lβ by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors, J. Pharm. Exp. Ther, 272, 1313 Wanidworanun, 1993, Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis, J. Immunol, 151, 6853, 10.4049/jimmunol.151.12.6853 Watson, 1993, Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides, Gynecol. Oncol, 49, 8, 10.1006/gyno.1993.1077 Weinberg, 1992, Inhibition of tumor necrosis factor alpha (TNFα) and interleukin-1 beta (IL-1β) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: Dissociation of acivicin-induced TNFα and IL-lβ mRNA expresion from acivicin-induce, Blood, 79, 3337, 10.1182/blood.V79.12.3337.bloodjournal79123337 Wells, 1981, Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment, Mol. Cell. Endocrinol, 23, 1, 10.1016/0303-7207(81)90112-X Wilson, 1991, A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide, J. Immunol. Meth, 139, 233, 10.1016/0022-1759(91)90193-J Yang, 1995, Pentoxifylline augments but does not antagonize TNFα-mediated neuroblastoma cell differentiation: modulation of calcium mobilization but not cAMP, Biochem. Biophys. Res. Commun, 211, 1006, 10.1006/bbrc.1995.1911 Zabel, 1989, Oxpentifylline in endotoxaemia, Lancet, 2, 1474, 10.1016/S0140-6736(89)92929-2 Zabel, 1993, Inhibition of endogenous TNF formation by pentoxifylline, Immunobiology, 187, 447, 10.1016/S0171-2985(11)80356-6 Zangerle, 1992, Direct stimulation of cytokines (IL-lβ, TNFα, IL-6, IL-2, IFNγ, GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis, Cytokine, 4, 249, 10.1016/1043-4666(92)90021-I